The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research.  

To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. 

In this episode, host Dr. Chunxia Su moderates a discussion in Mandarin Chinese about breakthrough advances in thoracic oncology presented at the conference with Dr. Zhengfei Zhu, Dr. Yun Fan, and Dr. Dongsheng Yue. 

Guests:
Dr. Yun Fan, MD, PhD 
Chief Expert of the Multidisciplinary Lung Cancer Team, Zhejiang Cancer Hospital; 
Senior Consultant (Grade II Chief Physician); Doctoral Supervisor 

Dr. Dongsheng Yue, MD, PhD 
Tianjin Medical University Cancer Institute and Hospital 

Dr. Zhengfei Zhu, MD, PhD 
Department of Radiation Oncology
Fudan University Shanghai Cancer Center

Live From WCLC 2026: Tuesday Highlights & Meeting Summary

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by Current sponsors: 
•	AbbVie 
•	AstraZeneca
•	Gilead
•	J&J
•	Summit